AUG 01, 2022 3:00 AM PDT

Cannabis Helps Cancer Patients Combat Nausea and Vomiting

WRITTEN BY: Katie Kokolus

A growing number of states have legalized marijuana for medical and/or recreational purposes.  Cannabis is a plant that produces resin-containing compounds called cannabinoids.  Cannabinoids, also known as phytocannabinoids, are chemicals that impact various biological systems, including the central nervous system and the immune system.  Delta-9-tetrahydrocannabinol (THC) is a psychoactive cannabinoid which means it has an impact on the brain.  Cannabidiol (CBD), another cannabinoid, is not psychoactive but still maintains therapeutic potential. 

While cannabis isn’t used as a drug to directly treat cancer patients, there is significant interest in using cannabis to manage the side effects of cancer and cancer therapies, such as anxiety, depression, pain, and nausea. 

In 1975 study tested cannabis in a randomized trial finding that THC reduced vomiting caused by chemotherapy.  Since 1985, three cannabis drugs have been FDA-approved to treat chemotherapy-induced nausea and vomiting.  Two of these approved drugs have the active ingredient dronabinol (Marinol and Syndros), and one is comprised of a synthetic cannabinoid, nabilone (Cesamet).  Recent studies continue to support the efficacy of these agents for managing these symptoms. 

A systemic review, including studies published up through August 2020, compared the use of cannabis to drugs established as antiemetics.  The study considered oral use of dronabinol and nabilone along with intramuscular administration of levonantradol, a synthetic form of dronabinol.  In total, the review considered over 1,300 patients from 30 separate studies.  The authors concluded that cannabinoids were more effective at reducing chemotherapy-induced vomiting than non-cannabis drugs such as prochlorperazine and chlorpromazine.  However, the study also found that side effects such as dizziness, depression, and arterial hypotension were more prominent in patients treated with cannabis agents. 

In 2020, a multicenter Phase II trial investigated a combined THC:CBD cannabis extract for chemotherapy-induced nausea.  The study found that the THC:CBD combination was associated with reduced nausea and vomiting.  Importantly, no additional side effects were observed in the patients receiving THC:CBD. 

The American Society for Clinical Oncology recommends using dronabinol or nabilone for cancer patients experiencing nausea.  While many cancer patients experience reduced nausea and vomiting from treatment with cannabis agents, the side effects should be closely monitored to ensure they don’t outweigh the benefits.    

 

Sources: NEJM, BMJ, Am J Med, Annal Oncol, J Clin Oncol

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
MAY 27, 2022
Cancer
Don't Forget the Sunscreen!
MAY 27, 2022
Don't Forget the Sunscreen!
Skin cancer is the most diagnosed type of cancer; however, about 99% of skin cancers are “non-melanoma skin cancer ...
JUN 06, 2022
Health & Medicine
Stagnant US Cervical Cancer Survival Rates
JUN 06, 2022
Stagnant US Cervical Cancer Survival Rates
According to JAMA Network, despite the overall cancer mortality rate decreasing since the 90s, cervical cancer survival ...
JUN 13, 2022
Cancer
Clinical Trial Demonstrates an Amazing 100% Response
JUN 13, 2022
Clinical Trial Demonstrates an Amazing 100% Response
The results of a Clinical Trial for rectal cancer patients published last week in the New England Journal of Medicine co ...
JUL 28, 2022
Clinical & Molecular DX
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
JUL 28, 2022
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
Pancreatic cancer typically does not cause symptoms until after it has spread to other organs. This makes it very diffic ...
JUL 19, 2022
Clinical & Molecular DX
As Rates of Thyroid Cancer Continue to Increase, Researchers Question Why
JUL 19, 2022
As Rates of Thyroid Cancer Continue to Increase, Researchers Question Why
Beginning in the early 1990’s, rates of thyroid cancer began to drastically increase. Though this trend has contin ...
Loading Comments...